Human RNA polymerase I-driven reverse genetics for influenza A virus in canine cells

Journal of Virology

Volumn 84, Issue 7, 2010, Pages 3721-3725

  Suphaphiphat, Pirada ^a   Keiner, Bjoern ^a   Trusheim, Heidi ^a   Crotta, Stefania ^a,b   Tuccino, Annunziata Barbara ^a   Zhang, Pu ^a   Dormitzer, Philip R ^a   Mason, Peter W ^a   Franti, Michael ^a  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (United States)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DIRECTED RNA POLYMERASE; DNA FRAGMENT; INFLUENZA VACCINE;

ARTICLE; CELL LINE; CELL STRAIN; HUMAN; INFLUENZA; INFLUENZA VIRUS A; MOLECULAR CLONING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANIMALS; CELL LINE; DOGS; HUMANS; INFLUENZA A VIRUS; INFLUENZA VACCINES; PROMOTER REGIONS, GENETIC; RNA POLYMERASE I;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 77949414468     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01925-09     Document Type: Article

References (17)

1. Bell, S. P., C. S. Ikaard, R. H. Reeder, and R. Jian. 1989. Molecular mechanisms governing species-specific transcription of ribosomal RNA. Cell 59: 489-497.
2. Bell, S. P., H. M. Jantzen, and R. Tjian. 1990. Assembly of alternative multiprotein complexes directs rRNA promoter selectivity. Genes Dev. 4:943-954.
3. Böttcher, E., T. Matrosovich, M. Beyerle, W. Garten, and M. Matrosovich. 2006. Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J. Virol. 80:9896-9898.
4. Cooper, J. K., G. Sykes, S. King, K. Cottrill, N. V. Ivanova, R. Hanner, and P. Ikonomi. 2007. Species identification in cell culture: a two-pronged molecular approach. In Vitro Cell. Dev. Biol. Anim. 43:344-351.
5. Fodor, E., L. Devenish, O. G. Engelhardt, P. Palese, G. G. Brownlee, and A. Garcia-Sastre. 1999. Rescue of influenza A virus from recombinant DNA. J. Virol. 73:9679-9682.
6. Heix, J., and I. Grummt. 1995. Species specificity of transcription by RNA polymerase I. Curr. Opin. Genet. Dev. 5:652-656.
7. Hoffmann, E., G. Neumann, Y. Kawaoka, G. Hobom, and R. G. Webster. 2000. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl. Acad. Sci. U. S. A. 97:6108-6113.
8. Lutz, A., J. Dyall, P. D. Olivo, and E. Hoffman. 2005. Virus-inducible reporter genes as a tool for detecting and quantifying influenza A virus replication. J. Virol. Methods 126:13-20.
9. Murakami, S., T. Horimoto, S. Yamada, S. Kakugawa, H. Goto, and Y. Kawaoka. 2008. Establishment of canine RNA polymerase I-driven reverse genetics for influenza A virus: its application for H5N1 vaccine production. Virol. J. 82:1605-1609.
10. Nakagawa, N., A. Maeda, T. Kase, R. Kubota, and Y. Okuno. 1999. Rapid detection and identification of two lineages of influenza B strains with monoclonal antibodies. J. Virol. Methods 79:113-120.
11. Neumann, G., K. Fujii, Y. Kino, and Y. Kawaoka. 2005. An improved reverse genetics system for influenza A virus generation and its implications for vaccine production. Proc. Natl. Acad. Sci. U. S. A. 102:16825-16829.
12. Okuno, Y., K. Tanaka, K. Baba, A. Maeda, N. Kunita, and S. Ueda. 1990. Rapid focus reduction neutralization test of influenza A and B viruses in microtiter system. J. Clin. Microbiol. 28:1308-1313.
13. Ozaki, H., E. A. Govorkova, C. Li, X. Xiong, R. G. Webster, and R. G. Webby. 2004. Generation of high-yielding influenza A viruses in African green monkey kidney (Vero) cells by reverse genetics. J. Virol. 78:1851-1857.
14. Parodi, B., O. Aresu, D. Bini, R. Lorenzini, F. Schena, P. Visconti, M. Cesaro, D. Ferrera, V. Andreotti, and T. Ruzzon. 2002. Species identification and confirmation of human and animal cell lines: a PCR-based method. Biotechniques 32:432-440.
15. Trusheim, H. 2006. A non-viral transformed new cell substrate used for production of vaccines. Cell Culture Engineering X, Whistler, British Columbia, Canada.
16. Trusheim, H., B. Roth, R. Wilms, S. Jung, R. Muth, M. Eggers, M. Enders, M. Elsen, C. Lenz-Bauer, K. Schwarz, S. Schneider, S. Kreibich, L. Dittmar, E. Veit, and T. Schaar. 2007. The MDCK 33016PF cell line is not only suitable for production of a cell-based influenza vaccine but is also an ideal substrate for influenza virus isolation. Options for Control of Influenza VI Conference, Toronto Canada.
17. Wang, Z., and G. M. Duke. 2007. Cloning of the canine RNA polymerase I promoter and establishment of reverse genetics for influenza A and B in MDCK cells. Virol. J. 4:102.